We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ALQGC.PA

Price
0.07
Stock movement up
+- (%)
Company name
Quantum Genomics SA
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Biotechnology
Market cap
5.02M
Ent value
6.99M
Price/Sales
413.88
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-34.46%
1 year return
-37.30%
3 year return
-66.87%
5 year return
-51.40%
10 year return
-37.58%
Last updated: 2025-04-12

DIVIDENDS

ALQGC.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales413.88
Price to Book-
EV to Sales576.02

FINANCIALS

Per share

Per share data
Current share count69.62M
EPS (TTM)-0.33
FCF per share (TTM)-0.33

Income statement

Income statement data
Revenue (TTM)12.13K
Gross profit (TTM)-2.48M
Operating income (TTM)-4.27M
Net income (TTM)-11.39M
EPS (TTM)-0.33
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)-20418.50%
Operating margin (TTM)-35196.28%
Profit margin (TTM)-93889.73%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash704.15K
Net receivables104.00K
Total current assets840.68K
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets891.68K
Accounts payable236.49K
Short/Current long term debt2.38M
Total current liabilities976.88K
Total liabilities2.67M
Shareholder's equity-1.78M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-11.46M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-11.46M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-1277.02%
Return on Invested Capital1039.18%
Cash Return on Invested Capital1045.70%

STOCK INFORMATION

Stock chart

Stock price data
Open0.07
Daily high0.07
Daily low0.07
Daily Volume0K
All-time high34.94
1y analyst estimate10.00
Beta0.71
EPS (TTM)-0.33
Dividend per share-
Ex-div date-
Next earnings date24 Apr 2025

Downside potential

Downside potential data
ALQGC.PAS&P500
Current price drop from All-time high-99.79%-12.89%
Highest price drop-99.98%-56.47%
Date of highest drop5 Sep 20249 Mar 2009
Avg drop from high-88.21%-11.07%
Avg time to new high265 days12 days
Max time to new high2906 days1805 days
COMPANY DETAILS
ALQGC.PA (Quantum Genomics SA) company logo
Marketcap
5.02M
Marketcap category
Small-cap
Description
Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure. It is developing firibastat, a treatment for high blood pressure, and in combination with others anti-hypertensive drugs. The company also is involved in the development of drugs for the treatment of high blood pressure as monotherapy and the prevention, as well as treatment of heart failure. Quantum Genomics Société Anonyme was incorporated in 2005 and is based in Paris, France.
Employees
3
Website
https://www.quantum-genomics.com
Investor relations
-
SEC filings
ALQGC.PA SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved